A new wave of sovereign capital is reshaping the economics of the critical minerals sector. From Washington and Canberra to Berlin, state-backed funds are becoming anchor investors, providing equity stakes and price floor guarantees for rare earth and strategic metal projects. This strategic pivot, a direct response to China’s control of over 90% of global rare earth processing and magnet capacity, is fundamentally altering the risk profile and valuation metrics for Western companies. We examine five firms at distinctly different stages of development, all riding this powerful trend.
Lynas Rare Earths: Expanding a Dominant Portfolio
As the world’s largest rare earths producer outside China, Lynas is methodically strengthening its market position. A recent milestone was the inaugural production of samarium oxide at its Malaysian plant, making it the sole non-Chinese commercial manufacturer of this material. This adds to the dysprosium and terbium it has produced since mid-2025, bringing its portfolio of heavy rare earths to three products.
The company’s shares trade around AUD 12.43, having gained nearly 60% year-to-date. Its 52-week range spans AUD 6.77 to AUD 21.96, with a market capitalisation of AUD 19.7 billion.
Two key agreements underpin sales security:
* JARE Agreement: Provides a price floor of USD 110/kg for neodymium-praseodymium (NdPr) oxide and commits to offtake at least 50% of all heavy rare earths from Malaysia.
* U.S. Department of Defense: A four-year, approximately USD 96 million award for light and heavy rare earth oxides, also featuring a USD 110/kg NdPr price guarantee.
For fiscal 2025, revenue grew 20% to AUD 556.51 million, though profit plummeted over 90% to AUD 7.99 million. Ten analysts recommend buying the stock, while four advise selling. The median price target is AUD 16.65. The next quarterly report on April 14 is expected to provide updates on the heavy rare earths ramp-up and the timeline for its U.S. processing facility in Texas.
MP Materials: Scaling Up the Value Chain
MP Materials announced a symbolic milestone in late March 2026: the first commercially scaled production of rare earth magnets. This moves the company beyond being a mere raw material supplier into the higher-margin segment of the value chain. Shares last traded around USD 53.29, with a market capitalisation of approximately USD 9.5 billion.
Its next step is ambitious. The planned “10X” facility in Northlake, Texas, aims to produce roughly 7,000 tonnes of magnets annually, supplementing the existing 3,000-tonne capacity in Fort Worth, where customers include General Motors and Apple. Construction is financed by USD 1 billion in bank debt from JPMorgan and Goldman Sachs, supplemented by a USD 150 million loan from the U.S. Department of Defense to expand separation capacity at the Mountain Pass site.
Key financial metrics show a clear trajectory:
* Adjusted loss per share 2025: -USD 0.24 (prior year: -USD 0.44)
* NdPr oxide production: +74% year-over-year
* Cash position: USD 1.83 billion, with a debt-to-equity ratio of 0.33
* Planned 2026 capital expenditure: USD 500–600 million
All 15 covering analysts rate the stock a buy. The median price target is USD 79.50, with a high of USD 94. The central risk remains the execution of the multi-billion dollar 10X project, a caution underscored by recent insider selling. Commissioning is expected in 2028, potentially creating the first fully integrated rare earth supply chain on U.S. soil in decades.
Arafura Rare Earths: Securing Cross-Continental Backing
Arafura has locked in binding agreements with two government investors: EUR 50 million (~AUD 84 million) from KfW on behalf of Germany’s raw materials fund and USD 100 million (~AUD 146 million) from Export Finance Australia. Combined, this raises the equity commitment for its Nolans Project to AUD 911 million.
On the day of the announcement, shares advanced 3.5% to AUD 0.29. They last traded at AUD 0.265, a 24-hour decline of 3.57%. Market capitalisation stands near AUD 1.26 billion.
The Nolans Project in Australia’s Northern Territory, slated for production start in the second half of 2029, is designed to supply about 4% of non-Chinese global NdPr oxide output. Binding offtake agreements with Hyundai, Kia, and Siemens Gamesa already cover 66% of planned capacity. Project management is taking shape with Hatch appointed as the preferred EPCM contractor.
Should investors sell immediately? Or is it worth buying Almonty?
However, the funding remains conditional on shareholder approval, finalisation of debt financing, and a deadline of December 2026. The company is currently loss-making (FY2026 result: -AUD 12.34 million, P/E: -52.48). Analysts see a 12-month price target of AUD 0.36. The stock’s trajectory will be defined by its transition from financing risk to construction risk.
Antimony Resources: A Speculative Leap on Strategic Interest
The most spectacular price movement within this group came from Antimony Resources. On April 2, 2026, its stock surged from a previous close of CAD 0.17 to CAD 1.53—a massive single-day gain. Market capitalisation climbed to approximately CAD 154 million. Its 52-week range is CAD 0.07 to CAD 1.65.
The euphoria was triggered by a visit from the Managing Director to the Hawthorne Army Depot in Nevada—the world’s largest ammunition storage facility—which included discussions with U.S. Department of Defense representatives regarding the company’s Bald Hill and Antimony 2.0 projects in New Brunswick.
Antimony has become a strategic bottleneck. The metal hardens lead alloys for ammunition, protects military equipment, and is used in semiconductors, infrared sensors, and specialty batteries for drones and communication systems. The global antimony market, currently valued at roughly USD 2.4–2.5 billion, is projected to grow to USD 4.1–4.4 billion by 2034/35.
Context is crucial: Antimony Resources is a pre-revenue explorer without a formal NI 43-101 resource estimate, reporting a diluted loss per share of CAD 0.07. The analyst price target is CAD 1.82. The stock is thinly traded and primarily driven by news flow. Without a concrete government contract or robust resource data, its risk-reward profile remains highly speculative.
Almonty Industries: A Pause After Exponential Gains
Following an unprecedented rally—a 139.67% gain over 90 days—Almonty has undergone a sharp correction. From an all-time high of CAD 30.58, shares fell roughly 26% by late March to around CAD 20.28. Seven consecutive losing days since mid-March triggered a technical sell signal.
The operational picture has evolved in parallel. With the Sangdong tungsten mine in South Korea now in production, supplemented by the Los Santos (Spain) and Panasqueira (Portugal) sites, the company is strategically expanding into the United States. Two tungsten projects in Montana, including the Gentung-Browns-Lake project, aim to pave its path to becoming a leading U.S. tungsten producer. Financing was secured via an upsized equity raise totalling USD 129.375 million.
Valuation warrants caution. A price-to-book ratio of 43.3x significantly exceeds the industry average of 23.7x and dwarfs the Canadian mining sector’s 3.4x multiple. Its latest quarterly revenue of CAD 8.70 million missed estimates of CAD 14.05 million. Eight analysts maintain a buy rating, with a median price target of CAD 23.71. The next quarterly report on May 20 must demonstrate tangible revenue growth from the Sangdong ramp-up to justify its premium valuation.
Sovereign Capital Meets Execution Reality
Together, these five companies represent the full maturity spectrum of critical mineral projects, from early-stage explorer to integrated magnet producer. The common denominator is clear: sovereign capital is rewriting the rulebook. Government-backed price guarantees, offtake commitments, and direct equity investments are lowering project risk while simultaneously establishing new valuation benchmarks.
The second quarter of 2026 brings pivotal moments. Arafura must meet the conditions for its KfW and EFA investments by December. MP Materials plans the groundbreaking for its 10X facility while ramping magnet production for GM. Lynas reports quarterly figures on April 14. Almonty must prove on May 20 that Sangdong is generating meaningful revenue. Antimony Resources requires hard geological data to fundamentally support its share price surge.
For each, a central question persists: Can operational milestones keep pace with the expectations already priced into their shares?
Ad
Almonty Stock: Buy or Sell?! New Almonty Analysis from April 4 delivers the answer:
The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 4.
Almonty: Buy or sell? Read more here...
